MDNews - Eastern Pennsylvania/Northwest New Jersey

May/June 2014

Issue link: https://viewer.e-digitaledition.com/i/321198

Contents of this Issue

Navigation

Page 5 of 15

AS THE U NITE D STATE S enters a new era of medica l treatment oversight, screenings such as routine mammography for breast cancer or PSA testing for prostate cancer have come under heavy scrutiny. Similarly, the timing, frequency and modality of colon and rectal cancer screenings with colonoscopy have been debated. The standard endorsed by the American Society of Colon & Rectal Surgeons — colonoscopy every 10 years starting at age 50 — has been critiqued as overly rigorous and not cost effective. The New York Times recently lambasted current colonoscopy screening guidelines, noting that "several cheaper and less invasive tests to screen for colon cancer are recommended as equally effective by the federal government's expert panel on preventive care … ." "We've defaulted to by far the most expensive option, without much if any data to support it," H. Gilbert Welch, MD, MPH, a Professor of Medicine at The Dartmouth Institute for Health Policy and Clinical Practice, told the newspaper. Yet since the 1980s, when colonoscopy was introduced, the incidence of colorectal cancer has fallen every year. "For my entire career, I have fought to prevent colon cancer for my patients," says John J. Stasik, MD, FACS, FASCRS, a colorectal surgeon at Lehigh Valley Colon and Rectal Specialists who has been in practice in the Lehigh Valley for over 40 years. "Like many others, I categorize tests into cancer screening tests versus cancer prevention tests. In no other cancer do we know of a specific premalignant lesion that can be removed safely with little risk, thereby prevent- ing the development of cancer. Many physicians consider finding colon cancer by barium enema or fecal occult blood testing a screening success. Every colon cancer patient on whom I have to operate, I consider a failure of prevention." With voices speaking from so many per- spectives, physicians need to give patients clear, well-reasoned guidance about screenings, based on current knowledge, says David S. Bub, MD, FACS, FASCRS, board-certified surgeon with Lehigh Valley Colon and Rectal Specialists. "Current screening guidelines are based on the premise that there is one important polyp — the adenoma — and one genetic pathway to colon cancer," Dr. Bub says. By Lehigh Valley Colon and Rectal Specialists BY FOCUSING ON THE DETECTION OF COLON POLYPS, SURGEONS AT LEHIGH VALLEY COLON AND RECTAL SPECIALISTS DRAW ON THEIR RESEARCH EXPERIENCE AND ONGOING INNOVATIONS TO PREVENT COLON CANCER. into Prevention of Colorectal Cancer COV ER FE AT UR E Drs. Stasik and Bub Provide New Insights 6 | Eastern Pennsylvania/NW New Jersey MD NEWS ■ M D N E W S . CO M

Articles in this issue

Archives of this issue

view archives of MDNews - Eastern Pennsylvania/Northwest New Jersey - May/June 2014